Drugmaker's Opioid Probe Costs Not Covered, 9th Circ. Says
By Ganesh Setty · March 9, 2022, 9:37 PM EST
U.S. Specialty Insurance Co. has no obligation to cover more than $4 million in costs an opioid drugmaker said it incurred while responding to a U.S. Department of Justice investigation, the...
To view the full article, register now.